- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Oxford Instruments plc, the high technology tools and systems company, issues today an Interim Management Statement which covers the period from 1 October 2007 to 14 January 2008, as required by the UK Listing Authority's Disclosure and Transparency Rules.
Our core environmental and nanotechnology markets remain robust despite market concerns over global economic conditions. Our Research and Development programme continues to convert our technological capabilities into innovative new products, meeting the needs of our customers. This combination of robust markets and commercially orientated innovation has helped to ensure that our organic growth plans remain on track. Furthermore, the integration of our two recent acquisitions, Vericold and WAS, is proceeding to plan with strong trading results to date from both companies.
Save as described in this statement, there has been no significant change in the financial position of the Group in the period. The Board continues to be confident that the Group's full year performance will meet expectations.
About Oxford Instruments plc
Oxford Instruments specialises in the design, manufacture and support of high-technology tools and systems for industry, research, education, space, energy, defence and healthcare.
We combine core technologies in areas such as low temperature and high magnetic field environments; X-ray, electron and optical based metrology; nuclear magnetic resonance, advanced growth, deposition and etching.
Our aim is to be the leading provider of tools and systems for the emerging nanotechnology and bioscience markets.
For more information, please click here
Oxford Instruments plc Tel: 01865 393200
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director
Hogarth Partnership Limited Tel: 020 7357 9477
Rachel Hirst / Andrew Jaques / Ian Payne
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017